Integrated BioPharma (OTCMKTS:INBP) Shares Up 0.4% – Time to Buy?

Shares of Integrated BioPharma, Inc. (OTCMKTS:INBP) were up 0.4% on Monday . The stock traded as high as $0.33 and last traded at $0.32. Approximately 42,400 shares traded hands during mid-day trading, an increase of 305% from the average daily volume of 10,462 shares. The stock had previously closed at $0.32.

Integrated BioPharma Stock Up 0.4 %

The stock has a market capitalization of $9.67 million, a P/E ratio of 15.97 and a beta of 0.59. The business has a fifty day moving average price of $0.31 and a 200-day moving average price of $0.25.

Integrated BioPharma (OTCMKTS:INBP) last posted its earnings results on Friday, September 20th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $12.75 million for the quarter. Integrated BioPharma had a net margin of 0.84% and a return on equity of 2.26%.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.